NCT05559879 2026-04-15Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaUniversity of Alabama at BirminghamPhase 1/2 Recruiting37 enrolled
NCT05277051 2026-03-23First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Active not recruiting152 enrolled